期刊文献+

肝细胞生长因子及C-Met的表达与宫颈癌浸润和转移的关系 被引量:5

The Correlation between Expression of the Hepatocyte Growth Factor and c-Met/hepatocyte Growth Factor Receptor and the Invasion and Metastasis of Uterine Cervix Cancer
下载PDF
导出
摘要 目的:研究肝细胞生长因子(HGF)及其受体C-Met在宫颈癌组织中的表达,探讨二者与宫颈癌浸润和转移的关系。方法:采用RT-PCR检测36例宫颈癌组织手术标本及31例正常宫颈组织标本中HGFmRNA和C-MetmRNA的表达,并进行相对定量研究。结果:宫颈癌组织中C-Met的阳性表达率显著高于正常宫颈组织。宫颈癌组织中,淋巴结转移组C-Met的表达水平高于未转移组;临床分期Ⅱ期组的表达水平高于ⅠB期组;中、低分化组的表达水平高于高分化组。结论:宫颈癌组织中存在C-Met的高表达,肿瘤细胞丰富的C-Met受体可能是通过与旁分泌途径获得的HGF结合而在宫颈癌浸润和转移的过程中发挥重要作用。 Objective: To investigate the expression level of the hepatocyte growth factor (HGF) and the c-Met/hepatocyte growth factor receptor mRNA in invasive cervical carcinoma and their associations with invasion and metastasis of cervical carcinoma. Methods: Expressions of the HGF mRNA and C-Met mRNA in postoperative samples of 36 cases with uterine cervix cancer and tissular samples of 31 cases with normal uterine cervix were determined using RT-PCR, and relative quantitation study was conducted. Results: The rate of positive c-Met mRNA expression in cervical carcinoma was significantly higher than that in normal uterine cervix. In primary tumors with the c-Met mRNA expression, the level in the group of lymphatic metastasis and of non-lymphatic metastasis was 1.6515±0.0850 and 1.2216±0.1191 respectively (P〈0.001); the level in the group with stage I B and stage Ⅱ was 1.2086± 0.1387 and 1.5497±0.1802 (P〈0.001), and the level in the group with the low and high grade was 1.4376±0.2387 and 1.2197±0.1419, respectively (P〈0.05). Conclusions: There is a high expression of c-Met mRNA in the group of invasive uterine cervical cancer, and the HGF/c-Met pathway may play an important role in the invasion and metastasis of cervical cancer.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2006年第21期1214-1216,共3页 Chinese Journal of Clinical Oncology
基金 黑龙江省自然科学基金资助(编号:D01-28)
关键词 宫颈癌 肝细胞生长因子及受体 肿瘤浸润 肿瘤转移 Uterine cervical carcinomas Hepatocyte growth factor C-Met/HGFR Invasion/metastasis of tumor
  • 相关文献

参考文献9

  • 1王岩,韩振国,李国栋,赵洪序,王东林.血清中肝细胞生长因子含量对非小细胞肺癌的影响[J].中国肿瘤临床,2004,31(4):204-207. 被引量:5
  • 2尹家俊,张锦瑜,宋燕,宗成国,胡祥.血清肝细胞生长因子水平与乳腺癌转移的关系[J].中国肿瘤临床,2003,30(7):478-479. 被引量:3
  • 3Wagatsuma S,Konno R,Sato S,et al.Tumor angiogenesis,hepatocyte growth factor,and c-met expression in endometrial carcinoma[J].Cancer,1998,82(3):520~530
  • 4Uchida D,Kawamata H,Omotehara F,et al.Role of HGF/c-met system in invasion and metastasis of oral squamous cell carcinoma cells in vitro and its clinical significance[J].Int J Cancer,2001,93 (4):489~496
  • 5Siegfried JM,Weissfeld LA,Luketich JD,et al.The clinical significance of hepatocyte growth factor for non-small cell lung cancer[J].Ann Thorac Surg,1998,66(6):1915~1918
  • 6Baykal C,Ayhan A,Al A,et al.Overexpression of the c-Met/HGF receptor and its prognostic significance in uterine cervix carcinoma[J].Gynecol Oncol,2003,88(2):123~129
  • 7Ghoussoub RA,Dillon DA,D'Aquila T,et al.Expression of cmet is a strong independent prognostic factor in breast carcinoma[J].Cancer,1998,82(8):1513~1520
  • 8Maulik G,Shriklande A,Kijima T,et al.Role of the hepatocyte growth factor C-Mat in oncogenesis and potential for therapeutic inhibition[J].Cytokine Growth Factor Rev,2002,13(1):41~59
  • 9连利娟.林巧稚妇科肿瘤学[M](第3版)[M].北京:人民卫生出版社,1999.317-323.

二级参考文献13

  • 1韩振国,马长金,JiangWG,李岩,马秀俐.肿瘤侵袭抑制因子-2对基因重组肝细胞生长因子诱导的人肺癌细胞运动和侵袭的抑制作用[J].中国生物制品学杂志,1996,9(3):106-109. 被引量:4
  • 2[1]Seslar SP, Nakamura T, Byers SW. Regulation of fibroblast hepatocyte growth factor/scatter factor expression by human breast carcinoma cell lines and peptide growth factor[J]. Cancer Res, 1993,53(6):1233~1238
  • 3[2]Gao M, Fan S, Goldberg ID, et al. Hepatocyte Growth Factor/Scatter Factor blocks the mitochondrial pathway of apoptosis signaling in breast cancer cells[J]. J Biol Ghem, 2001,276(50) :47257 ~47265
  • 4[3]Harvey P, Clark IM, Jaurand M-C, et al. Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases[J]. Br. J.Cancer, 2000,83(9):1145~1153
  • 5[4]Chakravarti A, Loeffler JS, Dyson NJ. Insulin-like Growth Factor Receptor I Mediates Resistance to Anti-EpidermalGrowth Factor Receptor Therapy in Primary Human Glioblastoma Ceils through Continued Activation of Phosphoinositide 3-Kinase Signaling[J]. Cancer Res, 2002,62(1):200~207
  • 6[5]Maehara N, Matsumoto K, Kuba K, et al. NK4, a fourkringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells[J]. Br. J. Cancer, 2001, 84(6):864~873
  • 7[6]Nakamura T, Matsumoto K, Kiritoshi A, et al. Induction of hepatocyte growth factor in fibroblasts by tuinor-derived factors affects invasive growth of tumor cells: in vivo analysis of tumor-stromal interactions[J]. Cancer Res, 1997,57(15):3305 ~3313
  • 8[7]Jiang WG, Grimshaw D, Lane J, et al. A Hammerhead Ribozyme Suppresses Expression of Hepatocyte Growth Factor/Scatter Factor Receptor c-MET and Reduces Migration and Invasiveness of Breast Cancer Cells[J]. Clin Cancer Res, 2001,7(8):2555~2562
  • 9[8]Taniguchi T, Kitamura M, Arai K, et al. Increase in the circulating level of hepatocyte growth factor in gastric patients[J].Br. J. Cancer, 1997,75(5):673~677
  • 10[9]Yamashita J, Ogawa M, Yamashita S, et al. Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer[J]. Cancer Res, 1994,54(7):1630~1633

共引文献13

同被引文献40

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部